The 16th World ADC San Diego, held from November 3–6, 2025, brought together industry leaders in San Diego, USA. Dr. Ting Xu, Founder, Chairman, and CEO of Alphamab Oncology, was invited to deliver a ...
News-Medical.Net on MSN
Fundamental challenges and cutting-edge strategies in developing new GBM CAR-T therapies
Glioblastoma (GBM), the most aggressive primary brain tumor, continues to portend a poor prognosis with median survival under ...
Patients with PsA have a higher prevalence of MetS compared with members of the general population and individuals with other inflammatory arthropathies.
In recognition of Pancreatic Cancer Awareness Month, join us to explore how cutting-edge technologies are transforming our ...
Optimizing icIEF identifies mAbs more accurately, while staying within European Pharmacopoeia and ICH guidelines.
Linvoseltamab (LINVO) + bortezomib (BTZ) in patients (pts) with relapsed/refractory multiple myeloma (RRMM): First results from the LINKER-MM2 trial. Belantamab ...
AID systems were associated with varying glycemic outcomes in type 1 diabetes, with MiniMed 780G users demonstrating best time in range.
In addition to working papers, the NBER disseminates affiliates’ latest findings through a range of free periodicals — the NBER Reporter, the NBER Digest, the Bulletin on Health, and the Bulletin on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback